Your browser doesn't support javascript.
loading
A non-conserved miRNA regulates lysosomal function and impacts on a human lysosomal storage disorder.
Frankel, Lisa B; Di Malta, Chiara; Wen, Jiayu; Eskelinen, Eeva-Liisa; Ballabio, Andrea; Lund, Anders H.
Affiliation
  • Frankel LB; Biotech Research and Innovation Center, University of Copenhagen, 2200 Copenhagen, Denmark.
  • Di Malta C; Telethon Institute of Genetics and Medicine (TIGEM), Federico II University, 80078 Naples, Italy.
  • Wen J; Department of Biology, University of Copenhagen, 2200 Copenhagen, Denmark.
  • Eskelinen EL; Department of Biosciences, Division of Biochemistry and Biotechnology, University of Helsinki, 00014 Helsinki, Finland.
  • Ballabio A; Telethon Institute of Genetics and Medicine (TIGEM), Federico II University, 80078 Naples, Italy.
  • Lund AH; Biotech Research and Innovation Center, University of Copenhagen, 2200 Copenhagen, Denmark.
Nat Commun ; 5: 5840, 2014 Dec 19.
Article in En | MEDLINE | ID: mdl-25524633
ABSTRACT
Sulfatases are key enzymatic regulators of sulfate homeostasis with several biological functions including degradation of glycosaminoglycans (GAGs) and other macromolecules in lysosomes. In a severe lysosomal storage disorder, multiple sulfatase deficiency (MSD), global sulfatase activity is deficient due to mutations in the sulfatase-modifying factor 1 (SUMF1) gene, encoding the essential activator of all sulfatases. We identify a novel regulatory layer of sulfate metabolism mediated by a microRNA. miR-95 depletes SUMF1 protein levels and suppresses sulfatase activity, causing the disruption of proteoglycan catabolism and lysosomal function. This blocks autophagy-mediated degradation, causing cytoplasmic accumulation of autophagosomes and autophagic substrates. By targeting miR-95 in cells from MSD patients, we can effectively increase residual SUMF1 expression, allowing for reactivation of sulfatase activity and increased clearance of sulfated GAGs. The identification of this regulatory mechanism opens the opportunity for a unique therapeutic approach in MSD patients where the need for exogenous enzyme replacement is circumvented.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfates / MicroRNAs / Multiple Sulfatase Deficiency Disease / Lysosomes Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2014 Document type: Article Affiliation country: Denmark

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfates / MicroRNAs / Multiple Sulfatase Deficiency Disease / Lysosomes Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2014 Document type: Article Affiliation country: Denmark